Treatment of peripubertal children after renal transplantation (RTX) with recombinant human growth hormone: Auxological data and effects on insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) during 24 months

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue 6, 1998, Pages 713-718

  Riedl, S ^a   Lebl, J ^b   Kluge, M ^a   Kreisinger, J ^b   Simkova E ^b   Kohlhauser, C ^a   Balzar, E ^a   Frisch, H ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chronic renal failure (CRF); GH therapy; IGFBP by Western ligand blotting; Pubertal development in RTX; Renal transplantation (RTX)

Indexed keywords

HUMAN GROWTH HORMONE; PREDNISONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE MATURATION; CHILD GROWTH; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; GLUCOSE INTOLERANCE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; PUBERTY; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; BLOTTING, WESTERN; BODY HEIGHT; CHILD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE CARE; PUBERTY; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 0031755250     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rizzoni G, Basso T, Setari M. Growth in children with chronic renal failure on conservative treatment. Kidney Int 1984; 26: 52-58.
2. Hokken-Koelega ACS, Stijnen T, de Muinck Keizer-Schrama SMPF, Blum WF, Drop SLS. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein -1 and -3, and cortisol in prednisone-trealed children with growth retardation after renal transplantation. J Clin Endocrinol Metab 1993; 11: 932-939.
3. Ingulli E, Singh A, Moazami S, Tejani A. Prednisone inhibits the efficacy of recombinant human growth hormone in pediatric renal transplant recipients. Kidney Int 1993; 43 (Suppl): S65-70
4. Van Es A. Growth hormone treatment in short children with chronic renal failure and after renal transplantation: combined data from European clinical trials. The European Study Group Acta Paedialr Scand 1991; Suppl 379: 42-48.
5. Fine RN, Yadin O, Moulten L, Nelson PA, Boechat MI. Lippe BH. Extended recombinant human growth hormone treatment after renal transplantation in children J Am Soc Nephrol 1992: 2 (Suppl 12): S274-283.
6. Van Dop C, Jabs KL, Donohoue PA, Bock GH, Fivush BA, Harmon WE. Accelerated growth rates in children treated with growth hormone after renal transplantation. J Pediatr 1992; 120: 244-250.
7. Bartosh S, Kaiser B, Rezvani I, Polinsky M, Schulman S, Palmer J, Baluarte HJ. Effects of growth hormone administration in pediatric renal allografts recipients. Pediatr Nephrol 1992; 6: 68-73.
8. Tönshoff B, Haffner D, Mehls O, Dietz M, Ruder H, Blum WF, Heinrich U, Stover B. Efficacy and safety of growth hormone treatment in short children with renal allografts. three year experience. Members of the German Study Group for growth hormone treatment in children with renal allografts. Kidney Int 1993; 44: 199-207.
9. Jabs K, Van Dop C, Harmon WE. Growth hormone treatment of growth failure among children with renal transplants. Kidney Int 1993; 43 (Suppl): S71-75.
10. Benfield MR, Parker KL, Bryson Waldo F, Overstreet SL, Kohaut EC. Treatment of growth failure in children after renal transplantation Transplantation 1993; 55: 305-308.
11. Hokken Koelega ACS, Stijnen T, de Ridder MAJ, de Muinck Keizer-Schrama SMPF, Wolff ED, de Jong MCJW, Donckerwolcke RA, Groothoff JW, Blum WF, Drop SL. Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 1994; 343: 1313-1317.
12. Mehls O, Haffner D, Wühl E, Tönshoff B. Schaefer F, Heinnch U and the German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Growth hormone as a new treatment modality for short children with chronic renal failure. Horm Res 1996; 46: 230-235.
13. Mentser M, Breen TJ, Sullivan EK, Fine RN. Growth hormone treatment of renal transplant recipients: the National Cooperative Growth Study experience - a report of the National Cooperative Growth Study and the North American Pediatric Renal Transplant Cooperative Study. J Pediatr 1997; 131: S20-24.
14. Tanner JM, Whitehouse RH, Marshall WA, Healy MJR, Goldstein H. Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 method). London-New York-San Francisco: Academic Press, 1975.
15. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am 1987; 34: 571-590.
16. Andersson HC, Markello T, Schneider JA, Gahl WA. Effect of growth hormone treatment on serum creatinine concentration in patients with cystinosis and chronic renal disease. J Pediatr 1992; 120: 716-720.
17. Laine J, Krogerus L, Sarna S, Jalanko H, Ronnholm K, Holmberg C. Recombinant human growth hormone treatment. Its effect on renal allograft function and histology. Transplantation 1996; 61: 898-903.
18. Maxwell H, Dalton RN, Nair DR, Turner C, Saunders AJ, Rigden SP, Rees L. Effects of recombinant human growth hormone on renal function in children with renal transplants. J Pediatr 1996; 128: 177-183.
19. Chavers BM, Doherty L, Nevins TE, Cook M, Sane K. Effects of growth hormone on kidney function in pediatric transplant recipients. Pediatr Nephrol 1995; 9: 176-181.
20. Schaefer F, Veldhuis JD, Stanhope R, Jones J, Schärer K and the Cooperative Study Group on Pubertal Development in Chronic Renal Failure. Alterations in growth hormone secretion and clearance in peri-pubertal boys with chronic renal failure and after renal transplantation. J Clin Endocrin Metabol 1994; 78: 1298-1306.
21. Mehls O, Tönshoff B, Kovacs G, Mayer C, Schurek J, Oh Y. Interaction between glucocorticoids and growth hormone. Acta Paediatr 1993; Suppl 388: 77-82.
22. Wehrenberg WB, Janowski BA, Piering AW, Cullier F, Jones KL. Glucocorticoids: potent inhibitors and stimulators of growth hormone secretion. Endocrinology 1990; 126: 3200-3203.
23. Miell JP, Taylor AM, Jones J, Holly JMP, Gaillard RC, Pralong FP, Ross RJM, Blum WF. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J Endocrinol 1993; 136: 525-533.
24. Miell JP, Buchanan CR, Norman MR, Maheshwari HG, Blum WF. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment. J Endocrinol 1994; 142: 547-554.
25. Price WA, Stiles AD, Moats-Staats BM, D'Ercole AJ. Gene expression of insulin-like growth factors (IGFs), the type I IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology 1992; 130: 1424-1432.
26. Swolin D, Brantsing C, Matejka G, Ohlsson C. Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells. J Endocrinol 1996; 149: 397-403.
27. Blum WF. Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: evidence for reduced secretion of IGFs. Acta Paediatr Scand 1991; Suppl 379: 24-31.
28. Lee D-Y, Park S-K, Yorgin PD, Cohen P, Oh Y, Rosenfeld RG. Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab 1994; 79: 1376-1382.
29. Gargosky SE, Pham HM, Wilson KF, Liu F, Giudice LC, Rosenfeld RG. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radio-immunoassay and ligand blotting. Endocrinology 1992; 131: 3051-3060.